MEDVi vs Ro

Both sell tirzepatide. MEDVi costs $399 a month and Ro costs $448, a difference of $49 a month or about $588 a year. What matters more is whether the two are dispensing the same category of product at all.

MEDVi is tablet and injection choice. Ro is branded medication with insurance help. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though it usually is once you have established that both dispense the same thing.

What is actually being dispensed. Ro publishes which pharmacy compounds its medication; MEDVi does not. On a product the FDA has not reviewed, that is not a small difference.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

What each discloses: MEDVi

• Tirzepatide tablet pricing is quoted after the intake questionnaire rather than published up front.

Where it wins: Injection pricing is consistent between the first month and renewals. Watch for: You have to complete intake before seeing tablet pricing. Injection pricing is published at $399.

What each discloses: Ro

• Membership does not include the cost of GLP-1 medication.
• Ro has exited compounded GLP-1s and works with FDA-approved branded products.

Where it wins: FDA-approved medication only, which removes the compounding-regulation question entirely. Watch for: The membership and the medication are two separate bills. A $39 first month does not mean a $39 prescription.

Each one’s strengths

MEDVi.

• Injection pricing is consistent between the first month and renewals.
• Tablet option for people who will not inject.

Ro.

• FDA-approved medication only, which removes the compounding-regulation question entirely.
• Genuine help pursuing insurance coverage.

Ro scores higher overall at 3.5 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

Which to choose

Decide on category first and price second. If one of these dispenses an FDA-approved product and the other a compounded preparation, you are not comparing like with like at any price. Where both are compounded, the pharmacy disclosure row is the next thing to weigh.

The verdict

On price alone, MEDVi at $399 a month is the more defensible choice on arithmetic alone. Ro earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: MEDVi and Ro.

How they sit against everyone else